What are our goals for PHD Industrial Holdings? When we acquire new businesses, we take a long-term view regarding their development, strategy, and growth plan; the same is true for our group as a whole. We have three key goals for PHD IH that we will achieve by following our simple formula of reinvesting funds into new platform subsidiaries as well as exploring buy-and-builds with our existing group companies. Our Corporate Compounder model allows us to promote long-term collaboration and is an ideal way to support and preserve British industry. Let’s have a coffee or a call if you want to find out more. #CorporateCompounder #PatientCapital #AcquisitiveConglomerate #Holdco
Peter Horton’s Post
More Relevant Posts
-
🌎 Breaking #records in international #SearchFund activity. Search funds are expanding globally, maturing into a powerful entrepreneurial pathway across diverse markets. IESE’s 2024 International Search Fund Report by Jan Simon and Rob Johnson highlights the continued growth and geographic expansion of search funds outside the U.S. and Canada, covering 320 #funds across 40 countries on 5 continents. Last year set new milestones with 59 new funds launched, 6 new countries involved, and 31 #acquisitions completed. Spain has led the way, launching the most #InternationalFunds in the past decade. Interested in learning more? Download the report for key insights: https://lnkd.in/ezAryG5r
To view or add a comment, sign in
-
🚧 Exciting times ahead with the Garuda Construction and Engineering IPO! 💼 Dive into key insights like price range, GMP, over-subscription, and more. Swipe to know our verdict for this IPO and the growth potential! 💰 #IPOAlert #GarudaEngineering #InvestmentOpportunity #StockMarketInsights #ConstructionIndustry #FinancialGrowth #IPOInvestments
To view or add a comment, sign in
-
How have life sciences deals performed over the last few years? Our Life Sciences deals paper summarizes notable European deals and trends of 2023 and provides an outlook for 2024. Explore our paper for more insights. #LifeSciences #Europe #Deals #MergersandAcquisitions #VentureCapital #IPO
To view or add a comment, sign in
-
How have life sciences deals performed over the last few years? Our Life Sciences deals paper summarizes notable European deals and trends of 2023 and provides an outlook for 2024. Explore our paper for more insights. #LifeSciences #Europe #Deals #MergersandAcquisitions #VentureCapital #IPO
Overview and outlook of European Life Sciences deals 2023 & 2024
kpmgswitzerland.smh.re
To view or add a comment, sign in
-
Building an M&A Function starts from your why! You need to understand why you are building the function, and what are the things you're hoping to achieve that is different from the organic business. It's important to realize that Corp Dev is more than just M&A, and you can do many things to achieve growth, such as joint ventures, investments, partnerships, etc. #mergersandacquisitions #mascience #corpdev #sourcing #standingupma
To view or add a comment, sign in
-
In 2023 in Europe, there were 604 corporate divestitures worth a total of £50.8bn, where a private equity fund either directly acquired a division from a company or as an add-on, according to PitchBook. This is up from 546 such deals in 2022. Already this year, the deal count has reached 54, worth £3.3bn. More in Citywire Wealth Manager 👇
PE firms look to boost returns through complex carve-out deals
citywire.com
To view or add a comment, sign in
-
🚀 Is your business navigating through a financial downturn? It's time for a strategic pivot towards prosperity! 💼💡 At Dawgen Global, we specialize in transforming organizations from challenging phases to robust financial health. Mergers & Acquisitions (M&As) and Turnarounds aren't just buzzwords for us; they are actionable strategies that we've mastered. 🌐 In 2021 alone, 360,000 M&A transactions were announced globally, with a significant portion aimed at reviving businesses in distress. Despite the complex nature of M&As, the ones executed with precision pave the way for remarkable revenue growth and improved profit margins. 📊 We understand the Caribbean market's intricacies and offer our expertise right at your doorstep. Whether you're in Jamaica or anywhere across the Caribbean, Dawgen Global is your go-to firm for integrated, multidisciplinary professional services at unparalleled value. 🌟 Don't let a downturn define your business's future. Let's collaborate to design a turnaround strategy that aligns with your goals and sets you on a path to financial recovery. 🔄 🔗 Dive Deeper into our success stories at: dawgen.global 📧 Ready for a turnaround? Connect with us at info@dawgen.global 📞 Reach out to our Caribbean Office at +1 876 6655926 or our USA Office at +1 786 673 3120. 📱 On the go? WhatsApp us globally at +1 876 493 4923 #DawgenGlobal #FinancialRecovery #TurnaroundStrategy #MergersAndAcquisitions #CaribbeanBusiness #Jamaica #BusinessGrowth #ProfitMargins
To view or add a comment, sign in
-
Discover why private equity firms prefer roll-ups to enhance efficiency, build market leaders, and create strategic value. Learn about the benefits of this investment strategy - https://shorturl.at/4ONuP #PrivateEquity #RollUpStrategy #MarketLeaders #Efficiency #Profitability #Acquisitions #Investment #BusinessGrowth #USPEC
To view or add a comment, sign in
-
Senior Manager Indirect Tax & Tax Technology | MBA | Transformation I Tax Data Management bei KPMG Switzerland
How have life sciences deals performed over the last few years? KPMG's Life Sciences deals paper summarizes notable European deals and trends of 2023 and provides an outlook for 2024. Explore it for more insights. #LifeSciences #Europe #Deals #MergersandAcquisitions #VentureCapital #IPO
Overview and outlook of European Life Sciences deals 2023 & 2024
kpmgswitzerland.smh.re
To view or add a comment, sign in
-
How have life sciences deals performed over the last few years? Our Life Sciences deals paper summarizes notable European deals and trends of 2023 and provides an outlook for 2024. Explore our paper for more insights. #LifeSciences #Europe #Deals #MergersandAcquisitions #VentureCapital #IPO
Overview and outlook of European Life Sciences deals 2023 & 2024
kpmgswitzerland.smh.re
To view or add a comment, sign in